nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.779	1	CbGaD
Methylergometrine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00726	0.045	CbGpPWpGaD
Methylergometrine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00705	0.0437	CbGpPWpGaD
Methylergometrine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00657	0.0407	CbGpPWpGaD
Methylergometrine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00599	0.126	CbGeAlD
Methylergometrine—HTR1F—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00412	0.0255	CbGpPWpGaD
Methylergometrine—HTR1E—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00388	0.024	CbGpPWpGaD
Methylergometrine—HTR1F—nervous system—Gilles de la Tourette syndrome	0.00384	0.0811	CbGeAlD
Methylergometrine—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.0037	0.0781	CbGeAlD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00339	0.021	CbGpPWpGaD
Methylergometrine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00333	0.0703	CbGeAlD
Methylergometrine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00321	0.0676	CbGeAlD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0032	0.0198	CbGpPWpGaD
Methylergometrine—HTR1F—brain—Gilles de la Tourette syndrome	0.00294	0.062	CbGeAlD
Methylergometrine—HTR1F—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00289	0.0179	CbGpPWpGaD
Methylergometrine—HTR1F—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00281	0.0174	CbGpPWpGaD
Methylergometrine—HTR1E—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00273	0.0169	CbGpPWpGaD
Methylergometrine—HTR1E—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00265	0.0164	CbGpPWpGaD
Methylergometrine—HTR1F—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00262	0.0162	CbGpPWpGaD
Methylergometrine—HTR1E—brain—Gilles de la Tourette syndrome	0.00255	0.0537	CbGeAlD
Methylergometrine—HTR1E—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00247	0.0153	CbGpPWpGaD
Methylergometrine—HTR1F—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00243	0.0151	CbGpPWpGaD
Methylergometrine—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00242	0.015	CbGpPWpGaD
Methylergometrine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00236	0.0499	CbGeAlD
Methylergometrine—HTR1F—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00236	0.0146	CbGpPWpGaD
Methylergometrine—HTR1E—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00229	0.0142	CbGpPWpGaD
Methylergometrine—HTR1E—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00223	0.0138	CbGpPWpGaD
Methylergometrine—HTR1F—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0022	0.0136	CbGpPWpGaD
Methylergometrine—HTR1E—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00207	0.0128	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00199	0.0124	CbGpPWpGaD
Methylergometrine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00195	0.0121	CbGpPWpGaD
Methylergometrine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00194	0.041	CbGeAlD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00188	0.0117	CbGpPWpGaD
Methylergometrine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00187	0.0395	CbGeAlD
Methylergometrine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00184	0.0387	CbGeAlD
Methylergometrine—HTR1F—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00183	0.0113	CbGpPWpGaD
Methylergometrine—HTR1E—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00173	0.0107	CbGpPWpGaD
Methylergometrine—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0017	0.0105	CbGpPWpGaD
Methylergometrine—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00165	0.0102	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00161	0.00997	CbGpPWpGaD
Methylergometrine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00161	0.00996	CbGpPWpGaD
Methylergometrine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0016	0.00994	CbGpPWpGaD
Methylergometrine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0016	0.00989	CbGpPWpGaD
Methylergometrine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00156	0.00965	CbGpPWpGaD
Methylergometrine—HTR1F—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00154	0.00954	CbGpPWpGaD
Methylergometrine—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00154	0.00953	CbGpPWpGaD
Methylergometrine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00151	0.0319	CbGeAlD
Methylergometrine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00149	0.00921	CbGpPWpGaD
Methylergometrine—DRD1—brain—Gilles de la Tourette syndrome	0.00149	0.0313	CbGeAlD
Methylergometrine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00145	0.0307	CbGeAlD
Methylergometrine—HTR1E—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00145	0.009	CbGpPWpGaD
Methylergometrine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00145	0.00899	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00143	0.00886	CbGpPWpGaD
Methylergometrine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.00142	0.0299	CbGeAlD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0014	0.00866	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00139	0.0086	CbGpPWpGaD
Methylergometrine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00137	0.0085	CbGpPWpGaD
Methylergometrine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.00137	0.0288	CbGeAlD
Methylergometrine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00135	0.00835	CbGpPWpGaD
Methylergometrine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00133	0.00825	CbGpPWpGaD
Methylergometrine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00131	0.00811	CbGpPWpGaD
Methylergometrine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.0013	0.00804	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00129	0.00801	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00128	0.00796	CbGpPWpGaD
Methylergometrine—Pergolide—DRD4—Gilles de la Tourette syndrome	0.00128	0.109	CrCbGaD
Methylergometrine—HTR1F—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00125	0.00773	CbGpPWpGaD
Methylergometrine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00124	0.00769	CbGpPWpGaD
Methylergometrine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00122	0.00756	CbGpPWpGaD
Methylergometrine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00119	0.00738	CbGpPWpGaD
Methylergometrine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00116	0.00717	CbGpPWpGaD
Methylergometrine—HTR2C—brain—Gilles de la Tourette syndrome	0.00115	0.0243	CbGeAlD
Methylergometrine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00115	0.00715	CbGpPWpGaD
Methylergometrine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00112	0.00694	CbGpPWpGaD
Methylergometrine—Lisuride—DRD4—Gilles de la Tourette syndrome	0.00111	0.0945	CrCbGaD
Methylergometrine—Pergolide—DRD3—Gilles de la Tourette syndrome	0.0011	0.0939	CrCbGaD
Methylergometrine—HTR2B—brain—Gilles de la Tourette syndrome	0.00108	0.0229	CbGeAlD
Methylergometrine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00108	0.00668	CbGpPWpGaD
Methylergometrine—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00668	CbGpPWpGaD
Methylergometrine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00104	0.00646	CbGpPWpGaD
Methylergometrine—Bromocriptine—DRD4—Gilles de la Tourette syndrome	0.00103	0.0876	CrCbGaD
Methylergometrine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00629	CbGpPWpGaD
Methylergometrine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.001	0.00621	CbGpPWpGaD
Methylergometrine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000973	0.00602	CbGpPWpGaD
Methylergometrine—Lisuride—DRD3—Gilles de la Tourette syndrome	0.000956	0.0815	CrCbGaD
Methylergometrine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000921	0.0194	CbGeAlD
Methylergometrine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000906	0.00561	CbGpPWpGaD
Methylergometrine—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000906	0.00561	CbGpPWpGaD
Methylergometrine—Bromocriptine—DRD3—Gilles de la Tourette syndrome	0.000886	0.0755	CrCbGaD
Methylergometrine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000869	0.00539	CbGpPWpGaD
Methylergometrine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000854	0.00529	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000814	0.00504	CbGpPWpGaD
Methylergometrine—Pergolide—DRD2—Gilles de la Tourette syndrome	0.000763	0.065	CrCbGaD
Methylergometrine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000757	0.016	CbGeAlD
Methylergometrine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000731	0.00453	CbGpPWpGaD
Methylergometrine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000729	0.0154	CbGeAlD
Methylergometrine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000701	0.0148	CbGeAlD
Methylergometrine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000675	0.0142	CbGeAlD
Methylergometrine—Lisuride—DRD2—Gilles de la Tourette syndrome	0.000662	0.0564	CrCbGaD
Methylergometrine—Methysergide—HTR2A—Gilles de la Tourette syndrome	0.000636	0.0542	CrCbGaD
Methylergometrine—Ergotamine—DRD2—Gilles de la Tourette syndrome	0.000636	0.0542	CrCbGaD
Methylergometrine—Bromocriptine—DRD2—Gilles de la Tourette syndrome	0.000613	0.0522	CrCbGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000601	0.00373	CbGpPWpGaD
Methylergometrine—Pergolide—HTR2A—Gilles de la Tourette syndrome	0.000589	0.0502	CrCbGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000584	0.00362	CbGpPWpGaD
Methylergometrine—HTR2A—brain—Gilles de la Tourette syndrome	0.000579	0.0122	CbGeAlD
Methylergometrine—HTR1E—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000567	0.00351	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000558	0.00346	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000551	0.00341	CbGpPWpGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000544	0.00337	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000542	0.00336	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000529	0.00328	CbGpPWpGaD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000527	0.00326	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000514	0.00318	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000513	0.00318	CbGpPWpGaD
Methylergometrine—Lisuride—HTR2A—Gilles de la Tourette syndrome	0.000511	0.0436	CrCbGaD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000511	0.00317	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000505	0.00313	CbGpPWpGaD
Methylergometrine—Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.000491	0.0419	CrCbGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000478	0.00296	CbGpPWpGaD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000476	0.00295	CbGpPWpGaD
Methylergometrine—Bromocriptine—HTR2A—Gilles de la Tourette syndrome	0.000474	0.0404	CrCbGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000464	0.00288	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000451	0.00279	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000438	0.00271	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000432	0.00268	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000408	0.00253	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000378	0.00234	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000367	0.00227	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000364	0.00226	CbGpPWpGaD
Methylergometrine—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000354	0.00219	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000354	0.00219	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000344	0.00213	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000342	0.00212	CbGpPWpGaD
Methylergometrine—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000334	0.00207	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000334	0.00207	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000329	0.00204	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000328	0.00203	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000319	0.00197	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000311	0.00192	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00031	0.00192	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000303	0.00188	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000301	0.00186	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000297	0.00184	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000286	0.00177	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000281	0.00174	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00028	0.00173	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000273	0.00169	CbGpPWpGaD
Methylergometrine—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000269	0.00167	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000265	0.00164	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000265	0.00164	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000258	0.0016	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000257	0.00159	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000254	0.00158	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000241	0.00149	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00024	0.00149	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00024	0.00148	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000231	0.00143	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00023	0.00142	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000227	0.00141	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000223	0.00138	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00022	0.00136	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000218	0.00135	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000217	0.00134	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000214	0.00133	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000208	0.00129	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000208	0.00129	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000208	0.00129	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000206	0.00127	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000205	0.00127	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000202	0.00125	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0002	0.00124	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000197	0.00122	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000196	0.00121	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000196	0.00121	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000194	0.0012	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000194	0.0012	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000194	0.0012	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000191	0.00119	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000188	0.00117	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000187	0.00116	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000186	0.00115	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000183	0.00113	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000181	0.00112	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000178	0.0011	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000178	0.0011	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000176	0.00109	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000176	0.00109	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000173	0.00107	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000171	0.00106	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000169	0.00105	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000168	0.00104	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000168	0.00104	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000168	0.00104	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000159	0.000988	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000156	0.000968	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00015	0.00093	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000146	0.000902	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000144	0.00089	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000136	0.000841	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00084	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00013	0.000807	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000128	0.000793	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000123	0.000762	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000121	0.00075	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000118	0.000733	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000118	0.000728	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000114	0.000707	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000112	0.000692	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000111	0.000686	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00011	0.000684	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00011	0.000681	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000109	0.000678	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000109	0.000678	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000107	0.000664	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000107	0.000661	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000104	0.000645	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000104	0.000642	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000103	0.00064	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000101	0.000626	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000101	0.000623	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.98e-05	0.000618	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.94e-05	0.000616	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.77e-05	0.000605	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.48e-05	0.000587	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.42e-05	0.000583	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.38e-05	0.000581	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.87e-05	0.000549	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.83e-05	0.000547	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.61e-05	0.000533	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.48e-05	0.000525	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.23e-05	0.00051	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.02e-05	0.000497	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.7e-05	0.000477	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.67e-05	0.000475	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.67e-05	0.000475	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.48e-05	0.000463	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.23e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.99e-05	0.000433	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.96e-05	0.000431	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.96e-05	0.000431	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.6e-05	0.000409	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.57e-05	0.000407	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.49e-05	0.000402	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.3e-05	0.000391	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.19e-05	0.000383	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.12e-05	0.000379	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.95e-05	0.000368	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.87e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000348	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	5.58e-05	0.000345	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.54e-05	0.000343	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.24e-05	0.000325	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.09e-05	0.000315	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.74e-05	0.000293	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.55e-05	0.000282	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.42e-05	0.000274	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.11e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.11e-05	0.000255	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.00024	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.32e-05	0.000206	CbGpPWpGaD
